cancer-patients / English

add

Sen. Jacky Rosen (D-Nev.) wants the Department of Health and Human Services (HHS) to investigate why a low-cost generic cancer drug isn’t widely available to patients. In a letter sent to HHS Tuesday shared first with The Hill, Rosen…

Liberal Democrat leader Sir Ed Davey has pledged to give every cancer patient a dedicated specialist nurse if his party can form a government.

Liberal Democrat leader Sir Ed Davey has pledged to give every cancer patient a dedicated specialist nurse if his party can form a government.

Liberal Democrat leader Sir Ed Davey has pledged to give every cancer patient a dedicated specialist nurse if his party can form a government.

(MedPage Today) -- Adding the mTOR inhibitor temsirolimus (Torisel) to chemotherapy in the first-line setting failed to improve event-free survival (EFS) among young patients with intermediate-risk rhabdomyosarcoma, a phase III trial from…

Southern Team Subaru partnered with the Leukemia and Lymphoma Society to surprise patients at Carilion Clinic's Inpatient Oncology unit with a donation.

A recommendation to a terminal cancer patient regarding a treatment that included CBD has cost a UK physician his medical license.

Researchers from the University of Michigan Health Rogel Cancer Center have discovered a biomarker that could help identify which renal cancer patients have a higher risk of recurrence.

A recent study conducted by researchers at University of Birmingham, in collaboration with University of Oxford, University of Nottingham and University Hospitals Birmingham NHS Foundation Trust, developed a new prediction model as an…

The genetics-based health tech company will serve as the organization's screening test for patients, ensuring the most targeted interventions possible for cancer treatment, recovery, and prevention

UP to 700 cancer patients are waiting more than six months for treatment, new figures show.

UP to 700 cancer patients are waiting more than six months for treatment, new figures show.

UP to 700 cancer patients are waiting more than six months for treatment, new figures show.

There is an urgent need to consider solutions to overcome complex access challenges to combination therapies — payers, policymakers and industry leaders must work together and act now to ensure access.

A study led by clinician-scientists and scientists from the National Cancer Centre Singapore (NCCS) and A*STAR's Genome Institute of Singapore (GIS) and funded by the National Research Foundation Singapore (NRF) has discovered unexpected…

With a new five-year, $2.78 million grant from the National Institutes of Health and National Cancer Institute, researchers at Case Western Reserve University(CWRU), Cleveland Clinic and University Hospitals (UH) will use artificial…

Scientists have identified a potential driver of aggressive lung cancer tumors in patients who live in areas with high levels of violent crime.

More than 106,500 adults will be diagnosed with colon cancer in 2024, according to the...

(MedPage Today) -- The combination of abemaciclib (Verzenio) plus fulvestrant (Faslodex) significantly improved progression-free survival (PFS) versus fulvestrant alone in patients with hormone receptor-positive/HER2-negative advanced…